You Searched For "Intellia Therapeutics" and got 14 results
Sort By:
1 min read
Intellia Therapeutics soars 63% after its gene-editing CRISPR therapy shows success in first human trials
Intellia partnered with Regeneron in 2016 to advance the CRISPR technology for in vivo therapeutic …
Matthew Fox
2 mins read
Intellia CEO: There won't be a 'next CRISPR'
CRISPR-Cas9 is a tool that that's often described as a kind of genetic scissors. It allows scientis…
Lydia Ramsey
3 mins read
A 68-year-old cofounded a biotech business instead of retiring. He's not getting paid for his work but values staying 'mentally engaged.'
Michael McCaman, 70, cofounded a biotech company in 2022 instead of retiring. He's not on payroll,…
John Towfighi
2 mins read
Stocks held by ARK Invest's flagship innovation fund have seen huge losses. Here are the fund's 10 biggest losers.
The flagship ARKK ETF is holding onto three stocks that are down more than 90% since Cathie Wood's …
Matthew Fox
5 mins read
Elon Musk is about to find out if ultimatums really work
In today's big story, we're looking at the ultimatum Elon Musk gave Tesla's board amid a critical t…
Dan DeFrancesco
2 mins read
Cathie Wood's Ark ETFs are surging on big gains in CRISPR gene-editing stocks following the success of first human trials
Ark Invest's Cathie Wood said last year that the next "FANG" stocks would likely come from the gene…
Matthew Fox
2 mins read
Editas surges 50% as ARK founder Cathie Wood sees genomic stocks driving returns for the next 5 years
Behind Tesla, the third largest holding in the ARKK ETF is CRISPR Therapeutics, a gene editing comp…
Matthew Fox
2 mins read
Warren Buffett outperforms Cathie Wood as tech stocks tumble and safer assets rise
Berkshire Hathaway stock has climbed 35% since the start of 2020, outpacing a 31% gain for Wood's f…
Theron Mohamed
2 mins read
Cathie Wood's flagship fund cashed out of Coinbase shares worth $25 million as the stock rose after bitcoin topped $57,000
Wood's Ark Innovation ETF sold more than 98,000 shares in the crypto exchange, worth about $25 mill…
Shalini Nagarajan
2 mins read
S&P 500, Nasdaq close at record highs as mega-cap tech spurs gains
US stocks jumped to new records to start the week. Facebook was handed a big win by a federal judge…
Isabelle Lee
2 mins read
A troubling link has been found between a cutting-edge gene-editing technology and cancer - and it's sending biotech stocks tumbling
The CEO of CRISPR Therapeutics said in a comment to STAT News that while the results are plausible,…
Charlotte Hu
4 mins read
The CEO of a premium stock-picking service says buy these 3 names to invest in the 3 most disruptive technological trends today
Simon Erickson, CEO of a premium stock-picking service, explained why these three sectors are likel…
Lisa Kailai Han
2 mins read
Wall Street just freaked out about a potential hiccup to a revolutionary gene editing technology - but it's not as bad as it seems
CRISPR Therapeutics chief scientific officer Dr. Bill Lundberg told Business Insider that the hope …
Lydia Ramsey
4 mins read
A blockbuster gene-editing tool has been 'linked' to cancer - here's how worried you should be
Earlier this week, reports linking the blockbuster gene-editing tool CRISPR to cancer in two stud…